KR930019219A - 만성 피로 증후군 치료제 - Google Patents

만성 피로 증후군 치료제 Download PDF

Info

Publication number
KR930019219A
KR930019219A KR1019930004190A KR930004190A KR930019219A KR 930019219 A KR930019219 A KR 930019219A KR 1019930004190 A KR1019930004190 A KR 1019930004190A KR 930004190 A KR930004190 A KR 930004190A KR 930019219 A KR930019219 A KR 930019219A
Authority
KR
South Korea
Prior art keywords
chronic fatigue
fatigue syndrome
polysaccharide
therapeutic agent
main chain
Prior art date
Application number
KR1019930004190A
Other languages
English (en)
Inventor
아쓰시 우찌다
Original Assignee
와끼야마 요시하루
가껭세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 와끼야마 요시하루, 가껭세이야꾸 가부시끼가이샤 filed Critical 와끼야마 요시하루
Publication of KR930019219A publication Critical patent/KR930019219A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/80—Geriatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/81—Energy rations, e.g. emergency rations, survival rations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

주쇄에 β-1,3- 글루코시드 결합을 갖는 다당류를 유효성분으로 함유하는 만성 피로 증후군 치료제.

Description

만성 피로 증후군 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 주쇄에 β-1,3-글루코시드 결합을 갖는 다당류를 유효성분으로 함유하는 만성 피로 증후군 치료제.
  2. 제1항에 있어서, 다당류가 시조피란인 치료제.
  3. 제1항에 있어서, 다당류가 렌티난인 치료제.
  4. 제1항에 있어서, 다당류가 쿠르들란인 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019930004190A 1992-03-18 1993-03-18 만성 피로 증후군 치료제 KR930019219A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP92-92158 1992-03-18
JP4092158A JPH05262654A (ja) 1992-03-18 1992-03-18 慢性疲労症候群治療剤

Publications (1)

Publication Number Publication Date
KR930019219A true KR930019219A (ko) 1993-10-18

Family

ID=14046623

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930004190A KR930019219A (ko) 1992-03-18 1993-03-18 만성 피로 증후군 치료제

Country Status (7)

Country Link
US (1) US5424300A (ko)
EP (1) EP0561408B1 (ko)
JP (1) JPH05262654A (ko)
KR (1) KR930019219A (ko)
AT (1) ATE139698T1 (ko)
CA (1) CA2091866A1 (ko)
DE (1) DE69303305T2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2947044B2 (ja) * 1993-01-27 1999-09-13 味の素株式会社 免疫不全症候群治療の補助療法剤
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US5990162A (en) * 1997-08-29 1999-11-23 Orphan Medical, Inc. Method for treatment of fibromyalgia and chronic fatigue syndrome
CA2339628C (en) * 1998-08-25 2008-06-03 Novartis Ag Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
JP4931375B2 (ja) * 2005-06-23 2012-05-16 均 伊藤 抗筋肉疲労剤及び飲食品
JP7150494B2 (ja) * 2017-12-08 2022-10-11 株式会社神鋼環境ソリューション 疲労感改善剤
JP2020080659A (ja) * 2018-11-16 2020-06-04 株式会社神鋼環境ソリューション Ｑｏｌ改善剤
CN113577233B (zh) * 2021-09-17 2022-07-22 深圳市宝安纯中医治疗医院 一种治疗慢性疲劳综合征的中药制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819480A (en) * 1969-09-11 1974-06-25 R Hochschild Composition of methionine with 2-dimethylaminoethanol
JPS554305A (en) * 1978-06-13 1980-01-12 Nippon Zoki Pharmaceut Co Ltd Remedy for disease caused by stress and its preparation
US5118673A (en) * 1982-05-07 1992-06-02 Carrington Laboratories, Inc. Uses of aloe products
SE466289B (sv) * 1984-09-19 1992-01-27 James Hoffman Makrofagstimulerande komposition jaemte foerfarande foer dess framstaellning
US5013739A (en) * 1986-10-07 1991-05-07 Bernard Bihari Method of treating chronic fatigue syndrome using an opiate receptor antagonist
US5162037A (en) * 1988-04-01 1992-11-10 Whitson Laboratories, Inc. Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome
US5126376A (en) * 1988-06-24 1992-06-30 Stephen Herman Method for treating viral infection using topical administration
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
CA1328074C (en) * 1988-09-01 1994-03-29 Shigenori Tanaka Horseshoe crab amebocyte lysate factor g inhibitor
EP0384798B1 (en) * 1989-02-06 1993-08-11 Gen-Ichiro Soma Limulus test-positive plant glycolipid, and method of stimulating the immuno system of an animal

Also Published As

Publication number Publication date
DE69303305T2 (de) 1997-02-06
EP0561408B1 (en) 1996-06-26
ATE139698T1 (de) 1996-07-15
DE69303305D1 (de) 1996-08-01
EP0561408A1 (en) 1993-09-22
US5424300A (en) 1995-06-13
CA2091866A1 (en) 1993-09-19
JPH05262654A (ja) 1993-10-12

Similar Documents

Publication Publication Date Title
KR890011606A (ko) 항응고제
NO982172L (no) Anvendelse av epinastin for behandling av smerter
ATE35418T1 (de) Oligosaccharide mit selektiver, antikoagulierender wirkung.
KR910000104A (ko) 투명 조성물
FI925926A (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
KR970020098A (ko) 항스트레스 조성물
KR880003616A (ko) 상처치료제
KR900004256A (ko) 살균제
KR930019219A (ko) 만성 피로 증후군 치료제
KR940008689A (ko) 항네프로제증후군제
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
IT1144697B (it) Derivato semi-sintetico della chitina processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
DK0519104T3 (da) Gel fremstillet ved complexdannelse af stivelse med en emulgator
BR1100612A (pt) Biconjugado apropriado contituìdo de dois sacarìdeos e um espaçador, seu uso e composição farmacêutica
EA199800778A1 (ru) Способ окисления полисахарида
KR910000114A (ko) 멜라닌 생성 억제 외용제
WO1996003413B1 (en) Regioselective sulfation
FI945446A (fi) Kotiinin käyttö tupakan vieroitusoireyhtymän lievittämiseksi
KR880001222A (ko) 동물사료
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
KR890011527A (ko) 살균성4,5-디클로로-1,2-디티올-3-온 조성물
KR930700119A (ko) 태아에 대한 기형발생원의 영향의 저지방법
KR890014119A (ko) 사이클릭 amp 유도체 연고제
KR930007451A (ko) 우리딘을 유효성분으로 함유하는 관절염 치료제
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid